Jeil Pharmaceutical
Jeil Pharmaceutical Co., Ltd., commonly referred to as Jeil Pharmaceutical, is a prominent player in the South Korean pharmaceutical industry, headquartered in the vibrant city of Seongnam, KR. Founded in 1973, the company has established itself as a leader in the development and manufacturing of innovative pharmaceuticals, particularly in the fields of oncology, cardiology, and neurology. With a strong commitment to research and development, Jeil Pharmaceutical offers a diverse portfolio of products, including prescription medications and over-the-counter solutions. Their unique approach to drug formulation and emphasis on quality have garnered recognition both domestically and internationally. Notably, Jeil has achieved significant milestones, including successful collaborations and expansions into key global markets, solidifying its position as a trusted name in healthcare.
DitchCarbon Score
How does Jeil Pharmaceutical's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Chemicals industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Jeil Pharmaceutical's score of 0 is lower than 70% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Jeil Pharmaceutical's reported carbon emissions
Jeil Pharmaceutical, headquartered in South Korea (KR), currently does not provide specific carbon emissions data or reduction targets. Without available figures on their emissions, it is challenging to assess their climate impact or commitments. However, the pharmaceutical industry is increasingly focusing on sustainability and reducing carbon footprints. Companies in this sector are often encouraged to adopt science-based targets and engage in initiatives aimed at minimising their environmental impact. As Jeil Pharmaceutical continues to navigate the evolving landscape of climate responsibility, further transparency regarding their emissions and commitments would be beneficial for stakeholders and the environment alike.
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Jeil Pharmaceutical is not committed to any reduction initiatives we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
